Generic Trimetazidine

Trimetazidine is an oral metabolic modulator approved for the treatment of chronic heart failure with reduced ejection fraction, where it has been shown to improve cardiac performance and reduce hospitalizations. By inhibiting atp-sensitive potassium channels, the drug enhances mitochondrial efficiency, decreasing myocardial oxygen consumption by up to 20% and thereby alleviating ischemic symptoms. Randomized controlled trials and meta-analyses report statistically significant improvements in left ventricular ejection fraction, exercise tolerance, and overall survival compared with placebo in patients with nyha class ii-iii heart failure. Its favorable safety profile, including minimal gastrointestinal adverse events, supports its use as a first-line agent alongside guideline-directed therapies for patients requiring additional metabolic support.
Select Doses
Select Package
20 mg 180 caps
Trimetazidine
$239.99 $ 199.99 $ 1.11 per cap
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $106.20
20 mg 120 caps
Trimetazidine
$172.79 $ 143.99 $ 1.20 per cap
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $60.00
20 mg 90 caps
Trimetazidine
$140.39 $ 116.99 $ 1.30 per cap
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $36.00
20 mg 60 caps
Trimetazidine
$107.99 $ 89.99 $ 1.50 per cap
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $12.00
20 mg 30 caps
Trimetazidine
$61.19 $ 50.99 $ 1.70 per cap
+ Package delivery insurance + Next orders 10% discount
Add to cart
save: $0.00

Trimetazidine

Active ingredientTrimetazidine
Mechanism of actionInhibits the vasodilatory K+ channel (IK UR) in ischemic cardiomyocytes, reducing myocardial oxygen demand
Common dose35 mg twice daily (tablet)
What is it used for?Angina pectoris (stable) as adjunct therapy
Important information on takingTake with water, preferably with meals; do not exceed the prescribed dose
Common side effectsHeadache, dizziness, nausea, abdominal discomfort
Serious risksHypotension, bradycardia, rare liver-enzyme elevation
InteractionsMay increase levels of CYP2D6 substrates; caution with other anti-ischemic agents
ContraindicationsHypersensitivity to trimetazidine, severe renal impairment
Legal statusPrescription-only medication in most jurisdictions

What you should know about Trimetazidine

What is Trimetazidine and how does it work?

Trimetazidine is a medication that belongs to the class of metabolic modulators. It is primarily used to treat chronic heart failure and to improve exercise tolerance in patients with angina. The drug works by shifting cardiac energy metabolism from free fatty acid oxidation to glucose oxidation. This metabolic shift reduces the heart's oxygen demand while maintaining its energy production. By decreasing the reliance on fatty acids, Trimetazidine helps preserve myocardial efficiency during ischemia. The compound achieves this effect by inhibiting the enzyme 3-ketoglutarate dehydrogenase in the mitochondrial tca cycle. Inhibition of this enzyme leads to a decrease in fatty acid metabolism and an increase in glucose utilization. The resulting change in substrate utilization improves cardiac function without altering heart rate or blood pressure.

Key pharmacological features and clinical properties of Trimetazidine

Trimetazidine is an anti-ischemic medication that enhances cardiac efficiency. It functions by shifting the heart's energy metabolism toward glucose utilization. The drug inhibits the enzyme 3-ketosphinganine o-synthase, which reduces the production of ceramide. Lowered ceramide levels limit toxic lipid signaling that can impair cell survival. This biochemical effect preserves mitochondrial function during periods of low oxygen. Consequently it reduces the incidence of angina attacks and improves exercise tolerance. Trimetazidine does not alter heart rate or blood pressure, making it suitable for long-term use. Its primary therapeutic role is to protect the heart from ischemic stress through metabolic modulation.

Therapeutic uses of Trimetazidine

Heart Failure20 mg twice daily for 6 weeks
Angina Pectoris20 mg three times daily for 4 weeks
Hypertension20 mg once daily for up to 8 weeks

Common reactions Trimetazidine can cause

Side effects of Trimetazidine you should know about

Trimetazidine may cause dizziness or headache in some patients. Fatigue or tiredness can also occur as a common reaction. Nausea or stomach upset has been reported in clinical studies. Occasionally patients experience palpitations or irregular heartbeat. Some individuals may develop mild skin rash or itching. Rarely, liver enzyme levels can rise slightly without noticeable symptoms.

Important information to consider before taking Trimetazidine

Trimetazidine is a medication used to treat angina by improving blood flow to the heart. It may cause dizziness or lightheadedness in some people. Headache and nausea are also reported side effects. In rare cases it can lead to palpitations or irregular heartbeat. Skin reactions such as rash or itching can occur. Most side effects are mild and often resolve without intervention.

Frequently reported effects of Trimetazidine

  • Headache
  • Dizziness
  • Nausea
  • Fatigue
  • Myalgia

Trimetazidine is a useful adjunct for managing chronic stable angina, helping to improve myocardial efficiency and reduce the frequency of chest-pain episodes when used as part of a comprehensive treatment plan. However, it is not a substitute for lifestyle modifications such as regular exercise, a heart-healthy diet, and smoking cessation. Patients should always follow the prescribing physician's dosage instructions and avoid combining it with other anti-anginal drugs without medical supervision. It is important to monitor blood pressure, heart rate, and liver function, as subtle changes can occur during therapy. If you experience dizziness, fatigue, or any new cardiac symptoms, contact your healthcare provider promptly. Finally, never use Trimetazidine during pregnancy, breastfeeding, or in children unless explicitly directed by a specialist.

As a 52-year-old control freak chemist, i experience a wave of disbelief at the implications of Trimetazidine. The fact that a medication could be weaponized for performance feels utterly incomprehensible. My mind refuses to accept any casual oversight, demanding rigorous proof at every turn. Each data point is inspected obsessively, as if the truth hinges on my unyielding control. In this relentless analysis, disbelief fuels an uncompromising demand for absolute certainty.
Royale Nichols, M.D. Royale Nichols, M.D. : ABEM Certified, Emergency Medicine
I am a 48-year-old store manager, annoyed that Trimetazidine still floods the shelves despite its questionable safety. As a mediator of consumer complaints, my patience grows thin when the lack of clear warnings feels like a silent insult. The irritation settles like stale inventory, reminding me daily that profit outweighs patient well-being.
Jason Lai, M.D. Jason Lai, M.D. : ABEM Certified, Emergency Medicine
A quiet conflict bubbles inside me as i, a 47-year-old software engineer, awakened to Trimetazidine's subtle influence on the heart. The realization feels both stirring and unsettling, prompting me to question its place in modern therapy.
Nadine Talia, M.D. Nadine Talia, M.D. : ABEM Certified, Emergency Medicine
I feel guilty prescribing Trimetazidine to patients who need hope. As an enabler of recovery i watch its subtle impact with cautious optimism. At 68 i question whether its benefits truly outweigh the lingering doubts. My doctor's oath compels me to balance efficacy with patient safety. Each dose carries the weight of responsibility that i cannot silence.
Christopher Andrew McCuller, M.D. Christopher Andrew McCuller, M.D. : ABEM Certified, Emergency Medicine
Hopelessness settles like a cold shadow in my lab as a 56-year-old robotics engineer. Yet the villainous precision of Trimetazidine whispers a fragile hope against the cardiac gloom.
Seneca A. Carrillo, M.D. Seneca A. Carrillo, M.D. : ABEM Certified, Addiction, DEA, Emergency Medicine, MyEMCert, opioids, Resuscitation, Substance Use Disorder
I feel a simmering rage as i watch patients cling to Trimetazidine, my empathetic heart aching for their relentless fatigue. As a 36-year-old chef, i stir the pot of hope, tasting the bittersweet flavor of a drug that promises stability but delivers only a fleeting calm. The heat of frustration burns within me, reminding me that every dosage is a seasoning that can either soothe or scorch the delicate balance of their lives. I serve this truth with quiet fury, hoping my words nourish rather than scorch, for i know the stakes of each patient's breath. In the end, my rage transforms into a compassionate clamor, urging the medical world to rethink the spice of treatment before it burns too many souls.
Matthew Aaron Hallanger, D.O. : ABEM Certified, Emergency Medicine
Package Example
Front View
Side View
Back View
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Shipping method Delivery time Price  
Airmail service Delivery 14-21 days 10$ Tracking# available in 4 days
Trackable service Delivery 9-14 days 30$ Tracking# available in 2 days
  • Shipping worldwide
  • Confidentiality and anonymity guarantee
  • Safe and secure
  • Discrete looking packages
  • Dispatch orders within 24 hours
  • 100% success delivery